Literature DB >> 11201041

Delayed embryonic development of mouse masseter muscle correlates with delayed MyoD family expression.

A Yamane1, Y Ohnuki, Y Saeki.   

Abstract

While the masseter muscle is known to have several unique developmental characteristics as compared with other skeletal muscles, little is known about its myogenesis. Thus, we examined the expression of myogenic marker and of myoD family gene mRNA from embryonic day (E) 11 to birth. The obtained results were compared with our earlier results of the mouse tongue muscle, which is also involved in oral functions. The mRNA quantities were determined by means of the reverse-transcription and competitive-polymerase chain-reaction techniques. The expression of myogenic marker mRNA indicated that differentiation and maturation in the masseter began at E13 as in the tongue, and were not yet completed at birth, although they were completed in the tongue. The expression of myoD, myogenin, and myf5 mRNA peaked later in the masseter (E17) than in the tongue (E13). The expression of MRF4 mRNA began later in the masseter (E15) than in the tongue (E13). These results suggest that the delayed expression of the myoD family genes in the masseter correlates with delayed differentiation and maturation, probably due to the later functional requirements of the masseter than of the tongue.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11201041     DOI: 10.1177/00220345000790120201

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  2 in total

1.  Functions of miR-1 and miR-133a during the postnatal development of masseter and gastrocnemius muscles.

Authors:  Megumi Nariyama; Manami Mori; Emi Shimazaki; Hitoshi Ando; Yoshiki Ohnuki; Tokuhisa Abo; Akira Yamane; Yoshinobu Asada
Journal:  Mol Cell Biochem       Date:  2015-05-16       Impact factor: 3.396

2.  Postnatal transitions in myosin heavy chain isoforms of the rabbit superficial masseter and digastric muscle.

Authors:  J A M Korfage; T van Wessel; G E J Langenbach; F Ay; T M G J van Eijden
Journal:  J Anat       Date:  2006-06       Impact factor: 2.610

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.